ANY SOLID TUMOR
Clinical trials for ANY SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ANY SOLID TUMOR trials appear
Sign up with your email to follow new studies for ANY SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Hard-to-Treat cancers with specific gene changes
Disease control OngoingThis early-stage study tests an oral drug called LY3410738 in people with advanced solid tumors that have IDH1 or IDH2 gene mutations, including bile duct cancer, cartilage cancer, and brain tumors. The main goals are to find the best dose and check safety. About 200 participants…
Matched conditions: ANY SOLID TUMOR
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New pill targets hard-to-treat cancers with RET gene mutations
Disease control OngoingThis study tests an oral drug called selpercatinib in people with advanced solid tumors that have a specific RET gene change. The goal is to see if the drug is safe and can shrink tumors. About 857 adults with lung, thyroid, colon, or other cancers took part. The drug is taken by…
Matched conditions: ANY SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 22, 2026 14:05 UTC